Abdominal X-ray might be a useful tool for assessing medication adherence in patients receiving Lanthanum carbonate
Control of the serum phosphate (P) level is the most important and challenging in dialysis patients, because hyperphosphatemia is closely associated with higher cardiovascular morbidity and mortality. Lanthanum carbonate (LC), which is a novel non-calcium phosphate P binder, is effective in decreasi...
Saved in:
Main Authors: | Hiroaki Ogata (Author), Fumihiko Koiwa (Author), Eriko Kinugasa (Author), Tadao Akizawa (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Body Mass Index Modified Predictive Ability Of Biomarkers For Protein-Energy Wasting In Prevalent Hemodialysis Patients
by: Hirokazu Honda, et al.
Published: (2012) -
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
by: Ismail A Mohammed, et al.
Published: (2008) -
Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease
by: Michael Keith, et al.
Published: (2016) -
Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials
by: Fang Wang, et al.
Published: (2018) -
Can Resistance Be Resolved with Lanthanum Carbonate in the Treatment of Hyperphosphatemia? A Multicenter Experience
by: Halil Zeki Tonbul, et al.
Published: (2023)